Nodular Ground-Glass Opacities on Thin-section CT: Size Change during Follow-up and Pathological Results by Lee, Hyun Ju et al.
22 Korean J Radiol 8(1), February 2007
Nodular Ground-Glass Opacities on 
Thin-section CT: Size Change during
Follow-up and Pathological Results
Objective: To evaluate the inter-group differences in growth and the pathologi-
cal results of nodular ground-glass opacities (GGOs) according to their size and
focal solid portions. 
Materials and Methods: Ninety-six nodular GGOs in 55 individuals followed by
CT for at least one month from an initial chest CT were included. Forty nodular
GGOs in 30 individuals were pathologically confirmed to be: adenocarcinoma (n =
15), bronchioloalveolar carcinoma (BAC) (n = 11), atypical adenomatous hyper-
plasia (AAH) (n = 8), focal interstitial fibrosis (n = 5) and aspergillosis (n = 1).
Lesions were categorized based on high-resolution CT findings: pure nodular
GGO (PNGGO)  10 mm, PNGGO > 10 mm, mixed nodular GGO (MNGGO) 
10 mm, and MNGGO > 10 mm. In each group, the change in size during the fol-
low-up period, the pathological results and the rate of malignancy were evaluated. 
Results: Three MNGGO lesions, and none of the PNGGO, grew during the fol-
low-up period. Resected PNGGOs  10 mm were AAH (n = 6), BAC (n = 5), and
focal interstitial fibrosis (n = 1). Resected PNGGOs > 10 mm were focal interstitial
fibrosis (n = 4), AAH (n = 2), BAC (n = 2), and adenocarcinoma (n = 2). Resected
MNGGOs  10 mm were adenocarcinoma (n = 2), and BAC (n = 1). Resected
MNGGOs > 10 mm were adenocarcinoma (n = 11), BAC (n = 3), and aspergillo-
sis (n = 1). 
Conclusion: Mixed nodular GGOs (MNGGOs) had the potential for growth;
most were pathologically adenocarcinoma or BAC. By contrast, PNGGOs were
stable for several months to years; most were AAH, BAC, or focal interstitial fibro-
sis. 
creening for lung cancer using chest CT is becoming more prevalent, and
small peripheral lung cancers are being detected more frequently.
According to the results of early data from the Early Lung Cancer Action
Project, 19% of positive findings on baseline screening CT were due to nodules
manifesting as ground-glass opacity (GGO) (1). Histologically, most nodular GGOs are
well differentiated bronchioloalveolar-type adenocarcinomas, bronchioloalveolar
carcinoma (BAC), or atypical adenomatous hyperplasia (AAH) (1, 2). 
The nodular GGO is a wispy, diagnostically frustrating pulmonary infiltrate, which is
being detected with increasing frequency as the resolution of CT improves. Physicians
are therefore increasingly asked to diagnose, manage and treat nodular GGO discov-
ered by CT scanning. Moreover, it is also known that the frequency of malignancy in
nodular GGO, including the solid portion, was much higher than in solid nodules (1,
2). However, there is suspicion that nodular GGO may represent over diagnosis of
lung cancer because it progresses so slowly it may be inconsequential. Because of the
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Sshort history of this new entity, its natural history is
unknown; thus a standard diagnostic scheme and treatment
strategies have not been fully established. However, if we
knew the factors that influence the progression of the
lesion and the malignant potential, there would be no need
to hesitate on decisions regarding surgical resection or
follow-up without intervention. The size, internal solid
portion and the morphology of the lesion may be consid-
ered as the factors important for such decisions. Among
the possible factors, we examined the significance of the
size and focal solid potions of the nodular GGOs in this
study. Therefore, the purpose of this study was to evaluate
the inter-group difference in the pattern of growth and the
pathological results of nodular GGOs after classification of
the lesions according to the size and focal solid portion. 
MATERIALS AND METHODS
Patients
From September 2002 to July 2005, nodular GGOs
smaller than 3 cm were found on chest CT in 93 individu-
als; follow-up thin-section CT (1 2.5 mm) were performed
in 64 individuals. Six lesions in six individuals were
confirmed as solid nodules on thin-section CT. Three
lesions in three individuals disappeared at the one-month
follow-up with thin-section CT. The remaining 96 nodular
GGOs in 55 individuals (M:F = 27:28; age range 44 80;
median age 58; mean age 59) were included in this study.
The lesions were followed by CT for at least one month
from the initial chest CT (1 49 months, mean 7 months).
Forty nodular GGOs in 30 individuals were pathologically
confirmed to be: adenocarcinoma (n = 15), BAC (n = 11),
AAH (n = 8), focal interstitial fibrosis (n = 5) and
aspergillosis (n = 1) by lobectomy (n = 30), wedge
resection (n = 9) and cutting needle biopsy (n = 1). Fifty-six
nodular GGOs in 25 individuals are currently being
followed by CT. Because of the retrospective nature of this
study, the decision for surgical biopsy was not based on
documented protocol. Management decisions were made
on a case by case basis with published data (1) and through
conference with physicians and surgeons. 
Patients with peripheral blood eosinophilia or the
possibility of hemorrhagic metastasis were excluded.
Thirty-eight individuals were non-smokers, 15 were
current smokers and two were ex-smokers. The lesions
were incidentally found in 53 individuals by regular
screening or as part of the evaluation of other diseases, one
was found by imaging work-up for hemoptysis, and
another by CT imaging for persistent whitish sputum. Eight
individuals had a history of a previous malignancy in a
variety of organs: stomach cancer (n = 2), bladder cancer
(n = 2), breast cancer (n = 1), chondrosarcoma (n = 1),
osteosarcoma (n = 1), and malignant fibrous histiocytoma
(n = 1). Three individuals had a concurrent adenocarci-
noma with a solid mass in other lobes of the lung. 
CT Imaging
In all individuals, a thin-section CT was performed at
least one time during the follow-up. In 24 individuals, thin-
section CT was performed with a LightSpeed-Ultra scanner
(GE Medical Systems, Milwaukee, WI) with 120 kVp, 400
mAs, a pitch of 0.875, and collimation of 1.25 mm. Images
were reconstructed with 1.25 mm thickness. In 18 individ-
uals, thin-section CT was performed with a Sensation-16
scanner (Siemens Medical Solutions, Erlangen, Germany)
with 140 kVp, 250 effective mAs, pitch of 1, and collima-
tion of 0.75 mm. Images were reconstructed with 1 mm
thickness. In four individuals, thin-section CT was
performed with a MX 8000 scanner (Phillips Medical
Systems, Netherlands) with 120 kVp, 150 mAs, pitch of
1.25, and collimation of 2.5 mm. Images were
reconstructed with 2.5 mm thickness. In five individuals,
thin-section CT was performed with a Somatom plus-4
(Siemens Medical Solutions) with 120 kVp, 300 mAs, pitch
of 1, and collimation of 1 2 mm. Images were
reconstructed with 1 2 mm thickness. In the remaining
four individuals, the thin-section CT was performed at
outside institutions with a variety of scanners with 120
140 kVp, 200 300 mAs, pitch of 1 1.5, collimation of
0.75 2.5 mm, and reconstruction thickness 0.75 2.5 mm.
In all individuals, scanning was performed at end inspira-
tion following hyperventilation.
Initial or follow-up chest CT was performed using a
variety of scanners including: Sensation-16, LightSpeed-
Ultra, MX-8000, Somatom plus 4, or HiSpeed Advantage
(GE Medical Systems). Chest CT was performed with 120
kVp, 200 300 mA, pitch of 0.875 1.5, and collimation of
0.75 8 mm. Images were reconstructed using high-
frequency algorithms with 1 8 mm thickness. 
Image Reading and Data Analysis
The CT images were read by three board-certified radiol-
ogists in consensus, each of whom had more than eight
years of experience in chest image interpretation. The
consensus results were documented. The number of
nodular GGOs at the initial CT and the presence of
mediastinal lymph node enlargement were initially
evaluated. 
We classified each lesion as to its type-pure nodular
GGO (PNGGO) or mixed nodular GGO (MNGGO)-on the
basis of the appearance on the thin-section CT scans. A
lesion was classified as MNGGO if it contained patches
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was classified as PNGGO if none of the lung parenchyma
within it was totally obscured. In making the distinction
between a PNGGO and a MNGGO, we did not regard
blood vessels as solid components despite their solid
appearance. 
The diameter of a nodule, as a measure of its size, was
defined as the average of its length and width measured
with electronic calipers on the image that showed the
largest cross-sectional area of the nodule. The diameter was
measured on the initial chest CT and on the final chest CT. 
Subsequently, we categorized nodular GGOs into four
groups on the basis of the size on initial CT and type on
the thin-section CT: PNGGO  10 mm, PNGGO > 10
mm, MNGGO  10 mm, and MNGGO > 10 mm. In each
group, we evaluated the change in size during the follow-
up period, and the pathological result. The rate of
malignancy and rate of adenocarcinoma were calculated
on a lesion by lesion basis. 
We graded the area of the solid portion in MNGGOs on
the thin-section CT scans with a four-point scale. Grade 1
was defined as a solid portion  25%, grade 2 as a solid
portion  50%, grade 3 as a solid portion  75% and
grade 4 as a solid portion > 75%. The change of size
during the follow-up period and the pathological results
according to the grade of solid portion was assessed. The
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Table 1. The Categorization of Nodular Ground-Glass Opacities and Change of Size during the Follow-up Period
Categorization PNGGO  10 mm PNGGO > 10 mm MNGGO  10 mm MNGGO > 10 mm
Follow-up Change Number  Change Number Change Number Change Number
Period in Size (Lesions/ in Size (Lesions/ in Size (Lesions/ in Size (Lesions/
Individuals) Individuals) Individuals) Individuals)
1 3 months No change 32/13 No change 6/ 6 No change  4/ 1 No change  14/13
Increase 1/ 1 Increase 1/ 1
4 6 months No change 7/ 3 No change 3/ 3 No change 3/ 3
7 12 months No change 2/ 2 No change 1/ 1 No change 1/ 1
13 24 months No change 10/ 2 No change 2/ 2 No change 2/ 2 No change 1/ 1
Increase 1/ 1
> 24 months No change 4/ 3 No change 1/ 1
Total (96/55) 55/23 13/13 11/ 8 17/16
Note. GGO = ground-glass opacity, PNGGO = pure nodular ground-glass opacity, MNGGO = mixed nodular ground-glass opacity
The sum of patient number is not matched with total number because of the patients with multiple lesions. 
Fig. 1. Pure nodular ground-glass
opacity in the right upper lobe confirmed
as atypical adenomatous hyperplasia in
a 62-year-old woman.
A. Initial CT shows 8 mm pure nodular
ground-glass opacity in the right upper
lobe. 
B. Thin-section CT after 10 months
shows persistent pure nodular ground-
glass opacity with the same size. The
lesion was pathologically confirmed by
right upper lobectomy. She had a history
of curative resection of adenocarcinoma
in the left upper lobe one year before. 
ABrate of malignancy and the rate of adenocarcinoma accord-
ing to the grade of solid portion were also evaluated. 
RESULTS
Forty-three individuals had a single lesion, five had two
lesions, two had three lesions, two had four lesions, one
had eight lesions, one had nine lesions and one had 12
lesions. In 12 individuals who had multiple lesions, nine
had only PNGGO and three had both types of GGOs.
None of the individuals had lymph node enlargement in
the mediastinum. The initial size of the 96 nodular GGOs
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Table 2. The Pathology of Nodular Ground-Glass Opacities and Change of Size during the Follow-up Period
Categorization PNGGO  10 mm PNGGO > 10 mm MNGGO  10 mm MNGGO > 10 mm
Follow-up Change Number Change Number Change Number Change Number
Period in Size (Lesions/ in Size (Lesions/ in Size (Lesions/ in Size (Lesions/
Individuals) Individuals) Individuals) Individuals)
1 3 months No change 8/5 No change 8/8 Increase 1/1 No change  14/13
Increase 1/1
BAC 5/2 Adenoca 2/2 Adenoca 1/1 Adenoca 11/10
AAH 2/2 BAC 2/2 BAC 3/3
Fibrosis 1/1 AAH 2/2 Aspergillosis 1/1
Fibrosis 2/2
4 6 months No change 3/1 No change 1/1 No change 1/1
AAH 3/1 Fibrosis 1/1 BAC 1/1
7 12 months No change 1/1 No change 1/1
AAH 1/1 Fibrosis 1/1
13 24 months Increase 1/1
Adenoca 1/1
Total (40/30) 12/7 10/10 3/3 15/14
Note. GGO = ground-glass opacity, PNGGO = pure nodular ground-glass opacity, MNGGO = mixed nodular ground-glass opacity, 
BAC = bronchioloalveolar carcinoma, AAH = atypical adenomatous hyperplasia, Adenoca = adenocarcinoma, Fibrosis = focal interstitial fibrosis
The sum of patient number is not matched with total number because of the patients with multiple lesions.
Fig. 2. Pure nodular ground-glass
opacity in the right upper lobe confirmed
as atypical adenomatous hyperplasia in
a 58-year-old man.
A. Initial thin-section CT shows a 15 mm
pure nodular ground-glass opacity in the
right upper lobe. 
B. On thin-section CT after 2 months, an
interval change was not noted. An
additional two pure nodular ground-
glass opacities were found in the right
upper lobe and one in the right middle
lobe. All lesions were pathologically
confirmed as atypical adenomatous
hyperplasia by multifocal wedge
resection.
ABwas 2 30 mm (mean, 9.7 mm). 
The results of categorization and change of size are
presented in Table 1. Fifty-five lesions in 23 individuals
were PNGGO  10 mm and 13 lesions in 13 individuals
were PNGGO > 10 mm. Eleven lesions in eight individuals
were MNGGO  10 mm and 17 lesions in 16 individuals
were MNGGO > 10 mm. For the PNGGOs, a change of
size was not noted in any lesion during follow-up (Fig. 1).
Two lesions in the MNGGOs  10 mm and one lesion in
the MNGGOs > 10 mm grew in size during the follow-up
period. 
Twelve lesions from the PNGGOs  10 mm, ten lesions
from the PNGGO > 10 mm, three lesions from the
MNGGO  10 mm and 15 lesions from the MNGGO > 10
mm were resected. The histological results and change of
size in each group are presented in Table 2. The resected
PNGGOs  10 mm were AAH (n = 6) (Fig. 1), BAC (n =
5), and focal interstitial fibrosis (n = 1). The resected
PNGGOs > 10 mm were focal AAH (n = 2) (Fig. 2), BAC
(n = 2), adenocarcinoma (Fig. 3) (n = 2) and interstitial
fibrosis (n = 4) (Fig. 4). The resected MNGGOs  10 mm
were adenocarcinoma (n = 2) and BAC (n = 1). The
resected MNGGOs > 10 mm were adenocarcinoma (n =
11) (Fig. 5), BAC (n = 3) and aspergillosis (n = 1) (Fig. 6).
Three lesions that had grown during the follow-up were
histologically confirmed as adenocarcinoma with mixed
Lee et al.
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Fig. 3. Pure nodular ground-glass
opacity in the right upper lobe confirmed
as adenocarcinoma in a 67-year-old
man.
A, B. Axial and coronal-reformatted
images of thin-section CT shows 25 mm
pure nodular ground-glass opacity in the
right upper lobe. The lesion was
pathologically confirmed by right upper
lobectomy. 
AB
Fig. 4. Pure nodular ground-glass
opacity in the right upper lobe confirmed
as focal interstitial fibrosis in a 61-year-
old man.
A. Thin-section CT shows 30 mm pure
nodular ground-glass opacity in the right
upper lobe. 
B. On follow-up CT scan after seven
months, an interval change was not
noted. The lesion was pathologically
confirmed by right upper lobectomy. On
pathologic slides, focal interstitial fibrosis
with exuberant type II pneumocyte prolif-
eration and alveolar macrophage collec-
tion were found. The cause of the focal
interstitial fibrosis was not confirmed. 
ABacinar and bronchioloalveolar patterns. Among 15
adenocarcinomas, 13 lesions were histologically confirmed
as well-differentiated or moderately-differentiated
adenocarcinoma with mixed acinar and bronchioloalveolar
types and two were as well-differentiated adenocarcinoma
with bronchioloalveolar type. 
In the resected lesions, the rate of malignancy on a lesion
basis was 42% (PNGGOs  10 mm), 40% (PNGGOs > 10
mm), 100% (MNGGOs  10 mm) and 93% (MNGGOs >
10 mm). The rate of adenocarcinoma was 0% (PNGGOs
10 mm), 20% (PNGGOs > 10 mm), 67% (MNGGOs 
10 mm) and 73% (MNGGOs > 10 mm).
The pathology and change in size during the follow-up
period according to the grade of the solid portion in the
MNGGOs are presented in Table 3. One lesion that had
grown during the follow-up was grade 2, another was
grade 3, and a third was grade 4. According to the grade of
the solid portion of the MNGGOs, the rate of malignancy
on a lesion by lesion basis was 83% (grade 1) and 100%
(grades 2 4). The rate of adenocarcinoma was 67% (grade
1), 100% (grade 2), 60% (grade 3) and 67% (grade 4).
DISCUSSION
The results of this study can be summarized as the
following: a) None of the PNGGOs showed considerable
change in size during the follow-up period; b) Most of the
PNGGOs were histologically AAH, BAC, or focal intersti-
tial fibrosis; c) We did not find adenocarcinoma among
PNGGOs  10 mm but, there were several adenocarcino-
mas among PNGGOs > 10 mm; d) Several MNGGOs grew
during the follow-up period and they were histologically
described as adenocarcinoma; e) In MNGGOs, the possibil-
ity of malignancy and the possibility of adenocarcinoma
were high, regardless of the grade of the solid portion. 
In this study, we introduced the term “nodular GGOs”.
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Fig. 6. Mixed nodular ground-glass opacity in the left upper lobe
confirmed as aspergillosis in a 52-year-old woman. Thin-section
CT shows 23 mm mixed nodular ground-glass opacity in the left
upper lobe. Multifocal solid portions were seen in the lesion. The
lesion was pathologically confirmed by CT-guided cutting needle
biopsy. She also had fungal sinusitis in the right maxillary sinus. 
Fig. 5. Mixed nodular ground-glass
opacity in the right lower lobe confirmed
as adenocarcinoma in a 61-year-old
man.
A, B. Axial and coronal-reformatted
images of thin-section CT shows 21 mm
mixed nodular ground-glass opacity in
right upper lobe. An elongated shaped
solid portion was noted in the lesion
(arrows). The lesion was pathologically
confirmed by right lower lobectomy. 
ABThe term “ground-glass” was introduced to describe not
only focal abnormalities but diffuse abnormalities as well.
Therefore, the adjective “nodular” was added. “Nodular
GGOs” is more appropriate than “focal GGOs” or
“localized GGOs” because the latter also represents
nonspecific irregular infiltration or mosaic attenuation of
the lung. 
Pure Nodular Grand-Glass Opacities
The Change in Follow-up
In the current study, PNGGOs remained stable over a
considerable time. None of PNGGO showed a change in
size during the follow-up period regardless of size. A long
doubling time for PNGGOs is already known. Hasegawa et
al. (3) reported a mean volume doubling time for PNGGO
tumors to be 813 days, which was significantly longer than
for MNGGO tumors with a solid central component (457
days) or in entirely solid nodules (149 days). Aoki et al. (4)
reported that all adenocarcinomas with Noguchi types A
(localized BAC) or B (localized BAC with foci of structural
collapse of alveoli) tumors with localized GGO (5) on high-
resolution CT had a tumor doubling time of more than one
year. Kodama et al. (6) reported that, among 19 PNGGOs
over a two-year follow-up, the size increased by more than
5 mm in five patients, increased up to 5 mm in six patients
and showed no change in eight patients. The resected
lesions were histologically BAC, adenocarcinoma, AAH,
focal fibrosis and lymphoproliferative disease. Kodama et
al. did not describe the CT parameters and the method of
measurement in their article. Many of the lesions were
inflammatory lesions such as lymphoproliferative disease.
The discrepancy between our results and those of Kodama
et al. might be caused by the difference in the follow-up
period, the method of measurement and CT parameters
and the difference in the disease entities studied.
Kakinuma et al. (7) reported that eight PNGGOs over six-
months changed during follow-up; five increased in size,
two decreased and one was stable in size with increasing
density. The discrepancy between our results and those of
Kakinuma et al. can be explained by the difference in
patient selection. We included all of the PNGGOs inciden-
tally detected by CT. By contrast, Kakinuma et al. only
enrolled the PNGGOs that were histologically confirmed
as lung cancer and were larger than 5 mm in diameter at
the time of the first thin-section CT. Moreover, in most of
the PNGGOs described by Kakinuma et al., the focal solid
portion appeared during the follow-up, and growth
occurred after the appearance of a focal solid portion.
Therefore the growth occurred when the nodule was a
MNGGO not a PNGGO (7). 
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Table 3. The Pathology and Change of Size during the Follow-up Period According to the Grade of the Solid Portion in Mixed
Ground-Glass Opacities
Grade 1 Grade 2 Grade 3 Grade 4
Categorization (Solid Portion  (25% < Solid Portion (50% < Solid Portion (75% < 
25%) 50%) 75%) Solid Portion)
Follow-up Change Number Change Number Change Number Change Number
Period in Size (Lesions/ in Size (Lesions/ in Size (Lesions/ in Size (Lesions/
Individuals) Individuals) Individuals) Individuals)
1 3 months No change 6/5 No change 3/3 No change  2/2 No change  3/3
Increase 1/1 Increase 1/1
Adenoca 4/3 Adenoca 4/4 BAC 1/1 Adenoca 2/2
BAC 1/1 Adenoca 2/2 BAC 1/1
Aspergillosis 1/1
4 6 months No change 1/1
BAC 1/1
7 12 months
13 24 months Increase 1/1
Adenoca 1/1
Total (18/17) 6/5 4/4 5/5 3/3
Note. GGO = ground-glass opacity, BAC = bronchioloalveolar carcinoma, AAH = atypical adenomatous hyperplasia, Adenoca = adenocarcinoma, 
Fibrosis = focal interstitial fibrosisThe Potential of Malignancy
Most of the PNGGOs in this study were histologically
AAH, BAC or focal interstitial fibrosis. Among PNGGOs
smaller than 10 mm, there were no cases of adenocarci-
noma. Two cases of PNGGOs larger than 10 mm were
adenocarcinoma. Theoretically, PNGGOs on high resolu-
tion CT (HRCT) should not possess a nonaerated
component suggesting adenocarcinoma in their pathologic
specimens, since nonaerated components usually appear as
focal solid portions on HRCT. This discrepancy may have
developed from partial volume averaging due to relatively
thick CT slices. One of two adenocarcinomas appeared as a
PNGGO on CT scanned with 2.5 mm slice thickness. By
contrast, other PNGGOs were scanned with 1 1.25 mm
slice thickness. The sizes of the nonaerated component of
the resected adenocarcinomas were smaller than 3 mm.
Nakajima et al. (8) reported that 10% of PNGGO lesions
were adenocarcinoma with stromal invasion. They
obtained HRCT images with 2 mm slice thickness.
Therefore, the detection of small nonaerated components,
which enable AAH or BAC to be distinguished from
adenocarcinoma, may be difficult with 2 2.5 mm slice CT.
To discriminate between adenocarcinoma, BAC and AAH,
a much higher resolution CT examination is needed.
Usually, a focal GGO due to acute inflammation or
bleeding disappears during a three month follow-up
period. However, PNGGOs due to focal interstitial fibrosis
remained stable over a several months in our study. These
lesions were histologically confirmed as focal interstitial
fibrosis with fibroblast and type II pneumocyte prolifera-
tion and collection of alveolar macrophages. Previous
investigators have suggested that a polygonal or flat shape
of the lesions represent advanced scar tissue as a result of
an inflammatory process from a variety of causes and that
the possibility of malignancy or AAH is substantially low
(9). 
Treatment Strategy of Pure Nodular Grand-Glass
Opacities
In this study the PNGGO smaller than 10 mm remained
stable for a considerable period of time. This data suggest
that most small PNGGOs might not progress to clinical
disease and may be included in the category of over
diagnosis bias. However, we still cannot recommend
follow-up thin-section CT without immediate diagnostic
intervention because of the discrepancy with previous
reports (6, 7). By contrast, when the PNGGO is larger than
10 mm or shows an increase in size or density, wedge
resection of the lesion should be recommended for the
purpose of a diagnostic intervention as choice of manage-
ment. Although, transthoracic CT-guided biopsy has
frequently offered an alternative to open surgical biopsy
for preoperative diagnosis, there are drawbacks to
transthoracic biopsy. For the differentiation of AAH, BAC
and adenocarcinoma, an adequate tissue sample including
the entire area of the lesion should be obtained. In
addition, BAC cannot be diagnosed based on a small
biopsy sample because the definition of BAC requires that
there be no evidence of invasive features within the entire
lesion (10). Moreover, three different kinds of histological
components could be mixed in a lesion with variable
proportions and focal adenocarcinoma can be missed with
transthoracic biopsy. 
Mixed Nodular Grand-Glass Opacities
The Change in Follow-up and the Potential of Malignancy
The MNGGO has potential for growth. In the current
study, all lesions that grew in size during the follow-up
were adenocarcinoma. These results suggest that MNGGO
may be a radiological manifestation of advanced cancer
with a short doubling time compared to PNGGO, which is
supported by results of a previous study (3). Our study also
showed that, regardless of the initial size of the lesion, the
rate of malignancy and the rate of adenocarcinoma were
high with the MNGGOs. Our results are consistent with
the report by Henschke et al. (1). They reported that, the
frequency of malignancy in MNGGO was much higher
than in solid nodules, and that the distribution by
malignancy type was strikingly different in the MNGGOs
as compared with solid nodules. The malignancies in
MNGGOs were typically BACs or adenocarcinomas with
bronchioloalveolar features, whereas for the solid nodules
the malignancies were typically other subtypes of
adenocarcinoma.
According to the 1999 WHO classification, BAC is
defined as a noninvasive tumor in adenocarcinoma (10).
AAH has been suggested to be a possible precursor to
BAC, and many studies have been conducted to character-
ize AAH (11 16). Both AAH and BAC without fibroblast
proliferation display a replacement growth pattern.
Theoretically, these lesions should therefore exhibit
PNGGOs on HRCT images. If this is true, HRCT images
could be used to distinguish precursor lesions and early (in
situ) carcinomas from invasive carcinomas. Among the
histologically confirmed MNGGO in our study, we could
not find any AAH lesions; all lesions were BAC or
adenocarcinoma except for one aspergillosis. In our study,
the separate classification of PNGGO and MNGGO was
helpful in the differentiation between AAH and adenocar-
cinoma. However, the classification did not contribute to
the differentiation of BAC from adenocarcinoma.
Interestingly, the grading of the internal solid portion of
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BAC from adenocarcinoma. In the three cases of proven
BAC in our study, the grade of the internal solid portion
on CT was 3 or 4; that is, the internal solid portion on CT
exceeded 50% of the lesion.
Treatment Strategy of Mixed Nodular Grand-Glass
Opacities
The potential for malignancy was very high in most
MNGGOs regardless of size. To avoid resection of focal
GGOs due to acute inflammation or bleeding, a three-
month follow-up CT should be recommended. If the lesion
remains on follow-up CT, the patient should then undergo
histological confirmation. For the lesions confirmed as
BAC or adenocarcinoma, the standard curative surgery
such as lobectomy should be considered. 
The extent of resection is somewhat controversial.
Several researchers have reported, although in retrospec-
tive studies, that limited resection may be an acceptable
alternative in patients with T1 N0 M0 disease and insuffi-
cient pulmonary reserve (17, 18). Recent reports have
suggested that patients with no invasive lesions such as
BAC or PNGGO on CT could be possible candidates for
limited resection (19 21). According to five-year follow-
up results in a prospective limited resection clinical trial,
lung tumors 2 cm or less in diameter with HRCT findings
of GGO, and without evident pleural indentations or
vascular convergence may be safely managed with only
limited resection (22). However, considering the probable
slow-growing nature of GGO lesions, five years of follow-
up is not long enough to conclude that the disease is cured.
Moreover, a limited resection would be acceptable only if
a BAC without an invasive component is correctly
diagnosed by frozen section of the tumor. This issue must
be studied in further investigations. 
A critique of our study is required. First, our investiga-
tion is limited to the relatively small number of pathologi-
cally confirmed nodular GGOs and relatively short period
of follow-up. Our study could be regarded as a preliminary
report of long-term follow-up. Secondly, our results were
not supported by statistical results. Long-term follow-up in
a larger series with a prospective design will be required to
elucidate the natural history of nodular GGO and to
determine whether surgical intervention is acceptable or
unnecessary, which may contribute to reduction of over
diagnosis bias. Third, we classified and graded nodular
GGO subjectively. A recently developed computerized
scheme (23, 24) may help detect and characterize nodular
GGOs. Fourth, serial CT scans in several individuals were
performed with different reconstruction thickness in the
same person. Therefore a fine structural change could have
been missed. 
In conclusion, MNGGOs had growth potential; most of
them were pathologically adenocarcinoma or BAC.
PNGGOs were stable for several months to years and most
of them were AAH, BAC or focal interstitial fibrosis. 
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